|
|
|
|
|
|
|
|
 |
Terry Provo,
EMT-P
Director of
Clinical Marketing
Located in: Minnesota
Phone: 651-403-5608
tprovo@advancedcirculatory.com
|
 |
Bill Dolbow, BA
Director of Field
Operations
Located in: Florida
Mobile: 561-248-3859
bdolbow@advancedcirculatory.com
|
|
|
|
|
|
|
Michael McLaury,
RN
ResQGARD Product
Manager
Located in: Ohio
Mobile: 216-789-2300
mmclaury@advancedcirculatory.com
Territory: CT, DE,
DC, ME, MD, MA, NH, NJ,
NY, OH, PA, RI, VT |
 |
Katie Talk,
CCEMTP, NREMT-P
Clinical Support
Specialist
Located in: North
Carolina
Mobile: 910-964-8899
ktalk@advancedcirculatory.com
Territory: AL, FL,
GA, MA, MD, NC, SC, VA |
|
|
 |
Cheya
Gerard,
NREMT-P
Clinical
Support Specialist
Located in: Minnesota
Mobile: 651-246-0530
cagerard@advancedcirculatory.com
Territory: AZ, IA, MN, MT, ND, NE,
NM, NV, OR, SD, VT,
WY, AK, CA, CO HI, ID,
OR, UT, WA |
 |
Tom Craft
Clinical Support
Specialist
Located in: Kentucky
Mobile: 765-721-7484
tcraft@advancedcirculatory.com
Territory: AR, KS,
MO, TN, WV, WI, IL, IN,
KY, MI, OH, WI |
|
|
 |
Richard Chin
Clinical Support
Specialist
Located in: Texas
Mobile: 214-491-0749
rchin@advancedcirculatory.com
Territory: MS, LA,
OK, TX |
|
|
|
|
|
|
|
|
Headquarters
|
|
|
|
|
|
The generally cleared
indication for the ResQPOD is a temporary increase in blood circulation
during emergency care,
 hospital,
clinic and home use.
Click here to review the Instructions for
Use. Studies are ongoing in the United States to evaluate the
long-term benefit of the ResQPOD for indications related to patients
suffering from cardiac arrest, hypotension during dialysis
and severe blood loss.
For more information on completed
clinical studies click here. The references on this website are not
intended to imply specific outcome-based claims not yet cleared by the
US Food and Drug Administration.
|
|
|
